Edwards: Surgical Valve Sales Slow As Transcatheter Valve Ramps Up
This article was originally published in The Gray Sheet
Executive Summary
Growth in Edwards Lifesciences surgical heart valve sales slowed in the first quarter due in part to pricing missteps, while the firm's nascent transcatheter heart valve business continued to pick up steam